For example, the potential of exogenous MUFA to mitigate ferroptosis without affecting ACSL3, as well as the dynamic regulation of drug resistance by lipid supply in the tumour microenvironment, necessitate additional investigation. Here, ACSL3 is linked to neoplasm.